Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy.
Abstract
No abstract available.
EDRN PI Authors
- (None specified)
Medline Author List
- Askin F
- Gabrielson E
- Li QK
- Osmani L